Outpatient Based Haploidentical Peripheral Blood Stem Cell Transplantation (HSCT) with Post-Transplantation Cyclophosphamide in Refractory/Relapsed Hematological Malignancies. Single Center Experience in Mexico

MLA

Paola Santana-Hernandez, et al. “Outpatient Based Haploidentical Peripheral Blood Stem Cell Transplantation (HSCT) with Post-Transplantation Cyclophosphamide in Refractory/Relapsed Hematological Malignancies. Single Center Experience in Mexico.” Biology of Blood and Marrow Transplantation, vol. 23, Mar. 2017, p. S272. EBSCOhost, https://doi.org/10.1016/j.bbmt.2016.12.175.

APA

Paola Santana-Hernandez, Olga G. Cantú-Rodríguez, Guillermo Sotomayor-Duque, Rosa Elena Lozano-Morales, Daniela Cárdenas-Araujo, Andrés Gómez-De León, César Homero Gutiérrez-Aguirre, Perla R. Colunga-Pedraza, & David Gómez-Almaguer. (2017). Outpatient Based Haploidentical Peripheral Blood Stem Cell Transplantation (HSCT) with Post-Transplantation Cyclophosphamide in Refractory/Relapsed Hematological Malignancies. Single Center Experience in Mexico. Biology of Blood and Marrow Transplantation, 23, S272. https://doi.org/10.1016/j.bbmt.2016.12.175

Chicago

Paola Santana-Hernandez, Olga G. Cantú-Rodríguez, Guillermo Sotomayor-Duque, Rosa Elena Lozano-Morales, Daniela Cárdenas-Araujo, Andrés Gómez-De León, César Homero Gutiérrez-Aguirre, Perla R. Colunga-Pedraza, and David Gómez-Almaguer. 2017. “Outpatient Based Haploidentical Peripheral Blood Stem Cell Transplantation (HSCT) with Post-Transplantation Cyclophosphamide in Refractory/Relapsed Hematological Malignancies. Single Center Experience in Mexico.” Biology of Blood and Marrow Transplantation 23 (March): S272. doi:10.1016/j.bbmt.2016.12.175.